Home › Funds › Eagle Health Investments LP › AXSM
Eagle Health Investments LP position in AXSM
AXSOME THERAPEUTICS INC. · Health Care
Eagle Health Investments LP reported holding 65,051 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$12.0M, representing 2.16% of its reported portfolio and ranking #17 among its reported holdings. Eagle Health Investments LP has disclosed AXSM holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Eagle Health Investments LP's AXSM position evolved
Eagle Health Investments LP first disclosed a stake in AXSM in Q2 2026 at 65,051 shares (US$15.9M). Across 2 filings, Eagle Health Investments LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 65,051 shares valued at US$12.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 65.05K | $15.92M | New |
| Q3 2026 | 65.05K | $11.99M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AXSM and 13F data
AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 49 other funds we track also report a position in AXSM — the largest reported positions include Deep Track Capital, LP (US$171.3M), ALETHEA CAPITAL MANAGEMENT, LLC (US$119.7M), Hood River Capital Management LLC (US$98.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AXSM
- Deep Track Capital, LP 700.00K sh · $171.34M · Q2 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 649.12K sh · $119.69M · Q3 2026
- Hood River Capital Management LLC 402.68K sh · $98.56M · Q2 2026
- Integral Health Asset Management, LLC 300.00K sh · $73.43M · Q2 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 254.28K sh · $62.24M · Q2 2026
- SAMLYN CAPITAL, LLC 246.01K sh · $60.22M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 300.10K sh · $55.34M · Q3 2026
- PFM Health Sciences, LP 219.60K sh · $53.75M · Q2 2026
- Tri Locum Partners LP 219.31K sh · $53.68M · Q2 2026
- First Turn Management, LLC 218.41K sh · $53.46M · Q2 2026
- Cannell & Spears LLC 259.65K sh · $47.88M · Q3 2026
More on Eagle Health Investments LP
FAQ
How long has Eagle Health Investments LP held AXSM?
Eagle Health Investments LP has disclosed AXSM holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Eagle Health Investments LP's current position in AXSM?
As of Q3 2026, Eagle Health Investments LP holds 65.05K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $11.99M, representing 2.16% of its reported portfolio and ranking #17.
Has Eagle Health Investments LP been buying or selling AXSM?
In the latest 13F filing (Q3 2026), Eagle Health Investments LP held unchanged its position in AXSM.
Which other funds hold AXSM?
Other major institutional holders of AXSM include Deep Track Capital, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Hood River Capital Management LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.